GLP ‐1 receptor agonists for treating obesity without diabetes: A systematic review and meta‐analysis of economic evaluations

Ähnliche Einträge

• Beyond diabetes and obesity: GLP ‐1 receptor agonists in disrupting the vicious cycle of metabolic dysfunction and neuroinflammation
  von: Renata Spezani, et al.
  Veröffentlicht: (2025)
• GLP ‐1 receptor agonists and cardiovascular events in metabolically healthy or unhealthy obesity
  von: Tommaso Bucci, et al.
  Veröffentlicht: (2025)
• The effect of GLP ‐1 receptor agonists on circulating inflammatory markers in type 2 diabetes patients: A systematic review and meta‐analysis
  von: Yifan Ren, et al.
  Veröffentlicht: (2025)
• Glucagon‐like peptide ‐1 receptor agonists in adolescents with overweight or obesity with or without type 2 diabetes multimorbidity—a systematic review and network meta‐analysis
  von: Muhammad Aaqib Shamim, et al.
  Veröffentlicht: (2024)
• Efficacy of GLP ‐1 receptor agonists in patients with obesity and heart failure with preserved ejection fraction: A systematic review and meta‐analysis of randomised controlled trials
  von: Armando Talavera, et al.
  Veröffentlicht: (2025)